Impact of Next-Generation Flow (NGF) Minimal Residual Disease (MRD) Monitoring in Multiple Myeloma (MM): Results from the Pethema/GEM2012 Trial

被引：0
作者：
Paiva, Bruno
Puig, Noemi
Cedena, Maria Teresa
Cordon, Lourdes
Vidriales, Maria-Belen
Burgos, Leire
Flores-Montero, Juan
Lopez-Anglada, Lucia
Gutierrez, Norma
Calasanz, Maria Jose
Martin-Ramos, Maria Luisa
Garcia-Sanz, Ramon
Martinez-Lopez, Joaquin
Oriol, Albert
Blanchard, M. Jesus
Rios, Rafael
Martin, Jesus
Martinez, Rafael
Sarra, Josep
Hernandez, Miguel T.
de la Rubia, Javier
Krsnik, Isabel
Moraleda, Jose M.
Palomera, Luis
Bargay, Juan
Orfao, Alberto
Rosinol, Laura
Mateos, Maria-Victoria
Lahuerta, Juan-Jose
Blade, Joan
San Miguel, Jesus F.
机构：
来源：
BLOOD | 2017年 / 130卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
905
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Upgraded Standardized Minimal Residual Disease Detection by Next-Generation Sequencing in Multiple Myeloma
    Yao, Qiumei
    Bai, Yinlei
    Orfao, Alberto
    Kumar, Shaji
    Chim, Chor S.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2020, 22 (05) : 679 - 684
  • [22] Clinical Utility of Next-Generation Flow-Based Minimal Residual Disease Assessment in Patients with Multiple Myeloma
    Kim, Hyun-Young
    Yoo, In Young
    Lim, Dae Jin
    Kim, Hee-Jin
    Kim, Sun-Hee
    Yoon, Sang Eun
    Kim, Seok Jin
    Cho, Duck
    Kim, Kihyun
    ANNALS OF LABORATORY MEDICINE, 2022, 42 (05) : 558 - +
  • [23] Clinical Significance of Sensitive Flow-MRD Monitoring in Elderly Multiple Myeloma Patients on the Pethema/GEM2010MAS65 Trial
    Paiva, Bruno
    Angeles Montalban, Maria
    Puig, Noemi
    Cordon, Lourdes
    Martinez-Lopez, Joaquin
    Ocio, Enrique M.
    Hernandez, Miguel
    Isabel Teruel, Ana
    Gironella, Mercedes
    Asuncion Echeveste, Maria
    Rosinol, Laura
    Martinez, Rafael
    Oriol, Albert
    Martin, Jesus
    Encinas, Cristina
    Carmen Gutierrez, Norma
    Vidriales, Mara-Belen
    Blade, Joan
    Jose Lahuerta, Juan
    Mateos, Maria-Victoria
    San Miguel, Jesus F.
    BLOOD, 2014, 124 (21)
  • [24] Minimal residual disease negativity by next-generation flow in non-CR myeloma patients
    Kim, Sung-Min
    Yang, Naery Euphrasia
    Jeong, Dajeong
    Yun, Jiwon
    Ryu, Sohee
    Yoon, Sung-Soo
    Ahn, Yong-Oon
    Lee, Dong Soon
    EJHAEM, 2020, 1 (02): : 563 - 566
  • [25] Interlaboratory Analytical Validation of a Next-Generation Sequencing Strategy for Clonotypic Assessment and Minimal Residual Disease Monitoring in Multiple Myeloma
    Medina, Alejandro
    Jimenez, Cristina
    Puig, Noemi
    Sarasquete, Maria Eugenia
    Flores-Montero, Juan
    Garcia-Alvarez, Maria
    Prieto-Conde, Isabel
    Chillon, Carmen
    Alcoceba, Miguel
    Gonzalez-Calle, Veronica
    Gutierrez, Norma C.
    Jacobsen, Austin
    Vigil, Edgar
    Hutt, Kasey
    Huang, Ying
    Orfao, Alberto
    Gonzalez, Marcos
    Miller, Jeffrey
    Garcia-Sanz, Ramon
    ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 2022, 146 (07) : 862 - 871
  • [26] Impact of Minimal Residual Disease Detection by Next-Generation Flow Cytometry in Multiple Myeloma Patients with Sustained Complete Remission after Frontline Therapy
    Terpos, Evangelos
    Kostopoulos, Ioannis, V
    Kastritis, Efstathios
    Ntanasis-Stathopoulos, Ioannis
    Migkou, Magdalini
    Rousakis, Pantelis
    Argyriou, Alexandra T.
    Kanellias, Nikolaos
    Fotiou, Despina
    Eleutherakis-Papaiakovou, Evangelos
    Gavriatopoulou, Maria
    Ziogas, Dimitrios C.
    Papanota, Aristea-Maria
    Spyropoulou-Vlachou, Marilyn
    Trougakos, Ioannis P.
    Tsitsilonis, Ourania E.
    Paiva, Bruno
    Dimopoulos, Meletios A.
    HEMASPHERE, 2019, 3 (06):
  • [27] "Friends and foes" of multiple myeloma measurable/minimal residual disease evaluation by next generation flow
    Pacelli, Paola
    Raspadori, Donatella
    Bestoso, Elena
    Gozzetti, Alessandro
    Bocchia, Monica
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [28] Next Generation Flow for highly sensitive and standardized detection of minimal residual disease in multiple myeloma
    Flores-Montero, J.
    Sanoja-Flores, L.
    Paiva, B.
    Puig, N.
    Garcia-Sanchez, O.
    Boettcher, S.
    van der Velden, V. H. J.
    Perez-Moran, J-J
    Vidriales, M-B
    Garcia-Sanz, R.
    Jimenez, C.
    Gonzalez, M.
    Martinez-Lopez, J.
    Corral-Mateos, A.
    Grigore, G-E
    Fluxa, R.
    Pontes, R.
    Caetano, J.
    Sedek, L.
    del Canizo, M-C
    Blade, J.
    Lahuerta, J-J
    Aguilar, C.
    Barez, A.
    Garcia-Mateo, A.
    Labrador, J.
    Leoz, P.
    Aguilera-Sanz, C.
    San-Miguel, J.
    Mateos, M-V
    Durie, B.
    van Dongen, J. J. M.
    Orfao, A.
    LEUKEMIA, 2017, 31 (10) : 2094 - 2103
  • [29] Next Generation Flow for highly sensitive and standardized detection of minimal residual disease in multiple myeloma
    J Flores-Montero
    L Sanoja-Flores
    B Paiva
    N Puig
    O García-Sánchez
    S Böttcher
    V H J van der Velden
    J-J Pérez-Morán
    M-B Vidriales
    R García-Sanz
    C Jimenez
    M González
    J Martínez-López
    A Corral-Mateos
    G-E Grigore
    R Fluxá
    R Pontes
    J Caetano
    L Sedek
    M-C del Cañizo
    J Bladé
    J-J Lahuerta
    C Aguilar
    A Bárez
    A García-Mateo
    J Labrador
    P Leoz
    C Aguilera-Sanz
    J San-Miguel
    M-V Mateos
    B Durie
    J J M van Dongen
    A Orfao
    Leukemia, 2017, 31 : 2094 - 2103
  • [30] Eight-color multiparameter flow cytometry (EuroFlow-NGF) is as sensitive as next-generation sequencing in detecting minimal/measurable residual disease in autografts of patients with multiple myeloma
    Urushihara, Ryota
    Takezako, Naoki
    Yoroidaka, Takeshi
    Yamashita, Takeshi
    Murata, Ryoichi
    Satou, Kenji
    Nakao, Shinji
    Takamatsu, Hiroyuki
    EJHAEM, 2023, 4 (01): : 184 - 191
12345